Pharvaris (PHVS) Payables (2019 - 2026)
Pharvaris (PHVS) posted Payables of $3.2 million for Q1 2026, down 46.71% on a QoQ basis from $6.0 million in Q4 2025, and down 28.63% year-over-year from $4.4 million in Q1 2025.
Pharvaris (PHVS) Payables (2019 - 2026) Analysis & Trends
Pharvaris' Payables history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- Quarterly Payables fell 28.63% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 28.63% YoY) and the FY2025 annual result came in at $5.8 million, up 17.0% from the prior year.
- Payables was $3.2 million for Q1 2026 at Pharvaris, down from $6.0 million in the prior quarter.
- Across five years, Payables topped out at $8.6 million in Q1 2023 and bottomed at $3.0 million in Q3 2025.
- A 5-year average of $5.0 million and a median of $4.8 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables jumped 139.39% — and 2023, when it plunged 54.1%.
- Pharvaris' Payables stood at $6.8 million in 2022, then plunged by 54.1% to $3.1 million in 2023, then soared by 55.75% to $4.9 million in 2024, then grew by 22.09% to $6.0 million in 2025, then plunged by 46.71% to $3.2 million in 2026.
- Business Quant data shows PHVS's Payables at $3.2 million in Q1 2026, $6.0 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.69 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 80.54 Mn |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.17 Mn |
| Dec 31, 2025 | 5.95 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | 5.50 Mn |
| Mar 31, 2025 | 4.45 Mn |
| Dec 31, 2024 | 4.88 Mn |
| Sep 30, 2024 | 4.61 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 6.04 Mn |
| Dec 31, 2023 | 3.13 Mn |
| Sep 30, 2023 | 4.83 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 8.62 Mn |
| Dec 31, 2022 | 6.82 Mn |
| Sep 30, 2022 | 7.15 Mn |
| Jun 30, 2022 | 4.45 Mn |
| Mar 31, 2022 | 3.77 Mn |
| Dec 31, 2021 | 2.85 Mn |
| Sep 30, 2021 | 4.54 Mn |
| Jun 30, 2021 | 4.03 Mn |